Repligen Corp. (RGEN)
168.36
+5.03
(+3.08%)
USD |
NASDAQ |
Jan 21, 14:49
Repligen Price: 168.36 for Jan. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Enovis Corp. | 23.72 |
| Perspective Therapeutics, Inc. | 2.545 |
| InfuSystem Holdings, Inc. | 8.66 |
| Xtant Medical Holdings, Inc. | 0.63 |
| VolitionRX Ltd. | 0.298 |
Price Related Metrics
| PE Ratio | 6525.58 |
| PS Ratio | 13.42 |
| Price to Book Value | 4.550 |
| Price to Free Cash Flow | 91.79 |
| Earnings Yield | 0.02% |
| Market Cap | 9.477B |
| Operating PE Ratio | 203.30 |
| Normalized PE Ratio | 280.41 |